Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00150215 | A First In Human Study Of PF-00184562 In Healthy Volunteers | PHASE1 | COMPLETED | 18 | — | — | Jul 1, 2005 | Oct 1, 2005 | Jul 25, 2006 | 1 | United States |
| Name | Type | Description |
|---|---|---|
| PF-00184562 | DRUG | - |
| Olanzapine | DRUG | - |
Inclusion Criteria: * Healthy male or female subjects of non-childbearing potential Exclusion Criteria: * Subjects with evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, pancreatic, psychiatric, neurologic, active ...